UK biotech Macrophage Pharma is a good example of how the burgeoning interest in immuno-oncology is leading to novel approaches for the treatment of cancer, in this case targeting the role of tumor-associated macrophages.
The company's technology switches the activity of such macrophages from maintaining an immunosuppressive environment around tumors to becoming immuno-stimulatory, enhancing...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?